PATENT CLAIM ANALYSIS

Application Number: 16003816
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-05
Patent Classification: ["514", "564000"]

Abstract:
Compositions of L-4-chlorokynurenic are provided, as are methods for the treatment of neurological dysfunction.

Claim (Index 14):
The pharmaceutical unit dose form of  claim 12 , wherein the pharmaceutical unit dose form is a tablet or a capsule.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 94.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15978855', '14762015', '16003793', '15018219', '12452936']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7932066038189206
- 35 USC 102 Novelty (BERT): 0.5440058463457113
- Combined Prediction Score: 0.7682865280715997
- Mean Citation Score: 353.91001399999993
- Max Citation Score: 411.50952
- Similarity Product: 246.97709793834687

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test